Skip to content

Clinical trials

Observational Pulmonary Arterial Hypertension trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Observational Status: Unknown status Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20121
20131
20144
20151
20161
20175
20182
20192
20203
20214
20221
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regina Steringer-Mascherbauer2
RenJi Hospital2
Silverleaf Medical Sciences INC2
Wuhan Asia Heart Hospital2
Association de Recherche en Physiopathologie Respiratoire1
Central Hospital, Nancy, France1
Chinese Academy of Medical Sciences, Fuwai Hospital1
Department of Pulmonary Circulation and Thromboembolic Diseases, Medical Center for Postgraduate Med1
Fatebenefratelli Hospital1
Fondazione IRCCS Policlinico San Matteo di Pavia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension32
Hypertension, Pulmonary5
Heart Failure3
Scleroderma, Systemic3
Familial Primary Pulmonary Hypertension2
Heart Defects, Congenital2
Acro-Osteolysis1
Aortic Valve Disease1
Cardiomyopathy, Hypertrophic1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.